Time to death and its predictors among HIV patients on antiretroviral therapy in public health facilities of Horro Guduru Wallaga zone, Ethiopia

A retrospective cohort study

Bibliographic Data

ID22082842
AuthorsBenti Morka, Firezer Belay Keno (Wollega University, corresponding author), Dejene Seyoum Gebre (0000-0002-5195-1389, Wollega University), Worku Fikadu (0000-0002-0324-1489, Wollega University), Gemechu Tiruneh (0000-0001-8304-5420, Wollega University), Eba Abdisa Golja (Wollega University), Adisu Ewunetu (Wollega University)
Year2025
Volume13
Pages1565573-1565573
Publication date2025-04-16
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2025.1565573
PMID40308933
OpenAlexW4409517316
LanguageEN
References cited34

Background People with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) continue to die at substantial rates, even in our nation of Ethiopia, despite receiving antiretroviral medication. Limited evidence is available regarding these individuals’ time to death and its predictors. Therefore, this study aimed to evaluate time to death and its predictors among HIV/AIDS patients receiving antiretroviral therapy (ART) in this study area. Objective The objective of the study was to assess time to death and its predictors among HIV patients receiving ART in public facilities of the Horro Guduru Wallaga (HGW) zone, Western Ethiopia, 2024. Methods and materials A facility-based retrospective study was conducted involving 538 HIV-positive patients on anti-retroviral therapy. A simple random sampling method was used to select a sample from patient registrations between October 2018 and October 2023. Data were entered into EpiData version 3.1 and exported to STATA version 14. The Kaplan–Meier curve was used to estimate the survival probability after ART initiation. The Cox regression model was used to identify independent predictors of death. Significantly associated variables were reported with a p -value of less than 0.05 and the adjusted hazard ratio (AHR) with a 95% confidence interval. Results Among the 538 study participants included in the final analysis, 42 (8%) individuals died. The finding of this study revealed that the incidence rate of HIV-related death was 2.81 deaths per 1,000 person-months. Diarrhea (AHR = 4.54; 95% CI 1.85–11.13), failure to take TB prophylaxis (AHR = 5.61; 95%CI: 2.25, 14.03), non-utilization of condoms (AHR = 2.62; 95% CI: 1.13, 6.08), and WHO clinical stages III and IV (AHR = 7.02; 95%CI: 3.11, 11.84) were identified as predictors of death among the patients. Conclusion The time to death among HIV patients on ART in this study area was higher compared to the national HIV-related death report. A history of diarrhea, failure to adhere to tuberculosis prophylaxis, non-utilization of condoms, and HIV clinical stages III and IV were found to be predictors of time to death related to HIV. Therefore, it is important to promote behavioral changes, such as condom utilization, adherence to TB prophylaxis, and effective treatment of comorbid infections, to improve the lifespan of HIV patients

ANTIRETROVIRAL AGENTS · Antiretroviral therapy · Cohort · Cohort study · Environmental health · Family medicine · Pathology · Public health · Retrospective cohort study · Viral load · HIV-related health complications and treatments · HIV/AIDS Impact and Responses · HIV/AIDS Research and Interventions · Medicine · Gerontology · Immunology · Internal Medicine

Tools

Open DOIOpen Access